Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development

Project Information

PHARMA-COG

Grant agreement ID: 115009

Project closed

Start date 1 January 2010

End date 31 December 2015

Funded under

• Specific Programme "Cooperation": Joint Technology Initiatives

Total cost € 30 715 556,00

EU contribution € 9 658 388,00

Coordinated by

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
United Kingdom